Mitochondrial diseases and mtDNA editing
- PMID: 38292200
- PMCID: PMC10825299
- DOI: 10.1016/j.gendis.2023.06.026
Mitochondrial diseases and mtDNA editing
Abstract
Mitochondrial diseases are a heterogeneous group of inherited disorders characterized by mitochondrial dysfunction, and these diseases are often severe or even fatal. Mitochondrial diseases are often caused by mitochondrial DNA mutations. Currently, there is no curative treatment for patients with pathogenic mitochondrial DNA mutations. With the rapid development of traditional gene editing technologies, such as zinc finger nucleases and transcription activator-like effector nucleases methods, there has been a search for a mitochondrial gene editing technology that can edit mutated mitochondrial DNA; however, there are still some problems hindering the application of these methods. The discovery of the DddA-derived cytosine base editor has provided hope for mitochondrial gene editing. In this paper, we will review the progress in the research on several mitochondrial gene editing technologies with the hope that this review will be useful for further research on mitochondrial gene editing technologies to optimize the treatment of mitochondrial diseases in the future.
Keywords: Gene editing; Mitochondrial DNA mutation; Mitochondrialdisease; Transcription activator-like effector nucleases; Zinc finger nucleases.
© 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Figures
Similar articles
-
Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review.Cytotherapy. 2024 Jan;26(1):11-24. doi: 10.1016/j.jcyt.2023.10.004. Epub 2023 Nov 6. Cytotherapy. 2024. PMID: 37930294 Review.
-
Advances in mitochondrial DNA base editing technology.Yi Chuan. 2023 Aug 20;45(8):632-642. doi: 10.16288/j.yczz.23-045. Yi Chuan. 2023. PMID: 37609815 Review.
-
Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs.Hum Gene Ther. 2024 Oct;35(19-20):798-813. doi: 10.1089/hum.2024.073. Epub 2024 Sep 24. Hum Gene Ther. 2024. PMID: 39212664
-
Trends and prospects in mitochondrial genome editing.Exp Mol Med. 2023 May;55(5):871-878. doi: 10.1038/s12276-023-00973-7. Epub 2023 May 1. Exp Mol Med. 2023. PMID: 37121968 Free PMC article. Review.
-
A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.Nature. 2020 Jul;583(7817):631-637. doi: 10.1038/s41586-020-2477-4. Epub 2020 Jul 8. Nature. 2020. PMID: 32641830 Free PMC article.
Cited by
-
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases.Brain Sci. 2024 Sep 5;14(9):899. doi: 10.3390/brainsci14090899. Brain Sci. 2024. PMID: 39335395 Free PMC article. Review.
References
-
- Fang T., Wang M., Xiao H., Wei X. Mitochondrial dysfunction and chronic lung disease. Cell Biol Toxicol. 2019;35(6):493–502. - PubMed
-
- Suomalainen A., Battersby B.J. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol. 2018;19(2):77–92. - PubMed
-
- Pereira C.V., Gitschlag B.L., Patel M.R. Cellular mechanisms of mtDNA heteroplasmy dynamics. Crit Rev Biochem Mol Biol. 2021;56(5):510–525. - PubMed
-
- Ghaoui R., Sue C.M. Movement disorders in mitochondrial disease. J Neurol. 2018;265(5):1230–1240. - PubMed
-
- Adashi E.Y., Rubenstein D.S., Mossman J.A., Schon E.A., Cohen I.G. Mitochondrial disease: replace or edit? Science. 2021;373(6560):1200–1201. - PubMed
Publication types
LinkOut - more resources
Full Text Sources